{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T17:30:29Z","timestamp":1768411829768,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Reproductive Immunology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jri.2017.08.001","type":"journal-article","created":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T23:34:15Z","timestamp":1501889655000},"page":"21-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Factors associated with adverse pregnancy outcomes in women with antiphospholipid syndrome: A multicenter study"],"prefix":"10.1016","volume":"122","author":[{"given":"Masashi","family":"Deguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideto","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Sugiura-Ogasawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamoru","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Miki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Makino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Murashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jri.2017.08.001_bib0005","first-page":"1","article-title":"PB 118: antiphospholipid syndrome","volume":"117","author":"ACOG","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jri.2017.08.001_bib0010","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00404-011-2055-y","article-title":"Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndrome","volume":"285","author":"Alalaf","year":"2012","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.jri.2017.08.001_bib0015","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jri.2017.08.001_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09537104.2017.1280150","article-title":"The role of platelets in antiphospholipid syndrome","author":"Baroni","year":"2017","journal-title":"Platelets"},{"key":"10.1016\/j.jri.2017.08.001_bib0025","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0002-9378(00)70500-X","article-title":"A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group","volume":"182","author":"Branch","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jri.2017.08.001_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(88)92859-0","article-title":"Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin","author":"Carreras","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jri.2017.08.001_bib0035","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1191\/096120399678847533","article-title":"Anticardiolipin and anti-beta2glycoprotein-I antibodies in patients with systemic lupus erythematosus: comparison between Colombians and Spaniards","volume":"8","author":"Cucurull","year":"1999","journal-title":"Lupus"},{"key":"10.1016\/j.jri.2017.08.001_bib0040","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12016-009-8144-z","article-title":"Predictors of pregnancy outcome in antiphospholipid syndrome: a review","volume":"38","author":"De Carolis","year":"2010","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jri.2017.08.001_bib0045","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/0961203312444172","article-title":"Complementemia and obstetric outcome in pregnancy with antiphospholipid syndrome","volume":"21","author":"De Carolis","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.jri.2017.08.001_bib0050","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijgo.2010.09.010","article-title":"Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome","volume":"112","author":"Fouda","year":"2011","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.jri.2017.08.001_bib0055","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/humrep\/det022","article-title":"Preconceptional low-dose aspirin for the prevention of hypertensive pregnancy complications and preterm delivery after IVF: A meta-analysis with individual patient data","volume":"28","author":"Groeneveld","year":"2013","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jri.2017.08.001_bib0060","first-page":"215","article-title":"Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986","volume":"68","author":"Harris","year":"1987","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jri.2017.08.001_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/0140-6736(93)91477-4","article-title":"The antiphospholipid syndrome: ten years on","author":"Hughes","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jri.2017.08.001_bib0070","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/HUMREP\/11.3.509","article-title":"beta 2-Glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women","volume":"11","author":"Katano","year":"1996","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jri.2017.08.001_bib0075","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1093\/humrep\/dep245","article-title":"Lower incidence of hypertensive complications during pregnancy in patients treated with low-dose aspirin during in vitro fertilization and early pregnancy","volume":"24","author":"Lambers","year":"2009","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jri.2017.08.001_bib0080","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3899\/jrheum.080763","article-title":"Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA trial","volume":"36","author":"Laskin","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jri.2017.08.001_bib0085","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/art.34402","article-title":"Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies","volume":"64","author":"Lockshin","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jri.2017.08.001_bib0090","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/14397595.2014.942503","article-title":"Clinical features and pregnancy outcome in antiphospholipid syndrome patients with history of severe pregnancy complications","volume":"25","author":"Matsuki","year":"2015","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jri.2017.08.001_bib0095","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jri.2017.08.001_bib0100","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1177\/0961203314537361","article-title":"Antiphospholipid scoring: significance in diagnosis and prognosis","volume":"23","author":"Oku","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.jri.2017.08.001_bib0105","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/art.33340","article-title":"Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events","volume":"64","author":"Otomo","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jri.2017.08.001_bib0110","series-title":"RCOG: the Investigations and Treaments of Couples with Recurrent First-trimester and Second-trimester Miscarriage NICE Guidel","author":"RCOG","year":"2011"},{"key":"10.1016\/j.jri.2017.08.001_bib0115","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0140-6736(05)63936-0","article-title":"From antiphospholipid syndrome to antibody-mediated thrombosis","volume":"350","author":"Roubey","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jri.2017.08.001_bib0120","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.thromres.2008.03.012","article-title":"Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy","volume":"123","author":"Ruffatti","year":"2009","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jri.2017.08.001_bib0125","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/rheumatology\/ker139","article-title":"Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study","volume":"50","author":"Ruffatti","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.jri.2017.08.001_bib0130","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1160\/TH06-01-0044","article-title":"Anti-\u03b22-glycoprotein I antibodies are associated with pregnancy loss in women with the lupus anticoagulant","volume":"95","author":"Sailer","year":"2006","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jri.2017.08.001_bib0135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12522-010-0056-3","article-title":"Intravenous immunoglobulin therapy for aspirin-heparinoid-resistant antiphospholipid syndrome","volume":"9","author":"Shimada","year":"2010","journal-title":"Reprod. Med. Biol."},{"key":"10.1016\/j.jri.2017.08.001_bib0140","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/j.1600-0412.2011.01236.x","article-title":"High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome","volume":"90","author":"Simchen","year":"2011","journal-title":"Acta Obs. Gynecol Scand"},{"key":"10.1016\/j.jri.2017.08.001_bib0145","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1191\/0961203304lu2011oa","article-title":"IVIG in APS pregnancy","volume":"13","author":"Triolo","year":"2004","journal-title":"Lupus"}],"container-title":["Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037817300931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037817300931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T01:57:59Z","timestamp":1569981479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165037817300931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":29,"alternative-id":["S0165037817300931"],"URL":"https:\/\/doi.org\/10.1016\/j.jri.2017.08.001","relation":{},"ISSN":["0165-0378"],"issn-type":[{"value":"0165-0378","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with adverse pregnancy outcomes in women with antiphospholipid syndrome: A multicenter study","name":"articletitle","label":"Article Title"},{"value":"Journal of Reproductive Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jri.2017.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}